Low testosterone becomes more common in aging men with weight and metabolic problems
Low testosterone (hypogonadism) increases with age and is especially common in older men with obesity and type 2 diabetes. Diagnostic standards and treatment approaches remain inconsistent across medical guidelines.
Why it matters: Understanding how obesity and metabolic disease relate to low testosterone can help doctors better identify and treat the condition in aging men.
Keep in mind: This is a review of existing literature, not a new clinical study, so it cannot establish whether treating low testosterone improves long-term health outcomes.
AI-assisted explanation based on the supplied abstract. Read the linked source for full context.
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Sep 9, 2026 · Discovered: Sep 18, 2026 · Assessed: — · Research update
What it does not prove
- Limitations have not yet been verified. Read the primary source.
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Systematic review
- Sample size
- —
- Duration
- —
- Population
- Aging men, with particular focus on those with obesity, type 2 diabetes mellitus, and other cardiometabolic comorbidities (functional hypogonadism), and comparison to younger men with congenital or acquired disorders affecting the hypothalamic-pituitary-testicular axis (organic hypogonadism)
- Primary outcome
- Diagnostic criteria, etiological assessment, and impact of treatment on symptoms and long-term health outcomes in older men with hypogonadism
- Effect size
- —
- Significance
- Not reported
- Journal
- Maturitas
- Published
- Sep 9, 2026
Sources
Primary source
- Maturitas ↗Peer reviewed
Assessment history
9/23/2026 · SUPERSEDED: Source updated; assessment withdrawn pending review.
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
No comments yet
Be the first to weigh in on this evidence.